Endogenous Serratia marcescens endophthalmitis in a preterm infant.
Latorre
Giuseppe
G
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D004352:Drug Resistance, Microbial; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery*; D015353:Eye Enucleation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D019102:Infant, Very Low Birth Weight; D011175:Positive-Pressure Respiration; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000628:therapy; D018570:Risk Assessment; D016868:Serratia Infections / Q000175:diagnosis* / Q000188:drug therapy; D012706:Serratia marcescens / Q000302:isolation & purification*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents